Public cancer patients being offered treatment that is second best to one in private system, conference hears
Minister for Health tells medicines industry conference he has sanctioned 34 new hires to speed up vetting process for new treatments
Amgen
‘I’ve certainly had career opportunities in the US I would never have had at home’
Wild Geese: Tralee woman Margaret Faul chased dream of working in early stage development of medicine
Irish jobs to go as Amgen cuts 350 employees worldwide after Horizon takeover
Amgen closed its $27.8bn acquisition of Dublin-based Horizon earlier this month
High Court paves way for Amgen’s €26.4bn takeover of Irish-based Horizon Therapeutics
Thursday’s approval of a takeover scheme of arrangement is the last remaining clearance for the acquisition
Amgen takeover of Horizon expected to close as FTC pauses challenge
US regulator open to settlement talks on concerns about monopoly access to drugs after losses in several high-profile cases
US targets 10 drugs for pricing negotiations in crackdown on costs
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
Regeneron boss backs bid to block $28bn Horizon Therapeutics deal
Leonard Schleifer describes largest pharma sector M&A of 2022 as ‘worst thing for our industry’
Investors pour record sums into high-grade corporate bonds
Higher yields and worries about riskier debt fuel stampede into investment-grade market
Mason Hayes & Curran’s revenue rises 8% to breach €100m milestone
Law firm is forecasting growth of 7-9 per cent in 2023 with a focus on expanding activity at international office locations
Irish Takeover Panel chief’s remuneration package rises by 37%
Report shows Michael Ryan received €256,086 for the 12 months to the end of June 2022
Amgen agrees €26.8bn deal for Dublin-based Horizon Therapeutics
Largest transaction in the pharma sector this year gives US biotech access to portfolio of rare disease drugs
Recruitment in life sciences sector widens search
Move towards valuing adaptable skills and culture fit over industry-specific experience
US biotech company Amgen to invest €88m in Dublin plant
Project is company’s largest outside North America
European shares inch up to record high for 10th consecutive session
Disney, Adidas and BHP Group among stocks to post gains
CJK buys McGrattan and Kenny and plans to create 100 engineering jobs
Brands to be retained as companies to co-exist under shared group structure
Modubuild aims to double revenues and may seek external funding
Company aiming to hit €100m revenue milestone in three years as demand soars
Ireland remains an attractive investment destination for US companies
Economy expected to rebound strongly in the second half of 2021 as Covid restrictions are eased
AstraZeneca breast cancer drug reduces recurrence rates, data shows
Lynparza may be effective medication for patients with BRCA genetic mutation
Iseq outpaces flat European peers as investors await policy news from US Fed
European bank stocks rise on positive trading updates
European shares rebound as progress on Brexit trade deal overshadows virus worries
EU-UK rift over fishing narrows as deadline for deal approaches
Transatlantic relationship boosts Irish economy and exchequer
Foreign direct investment underpins US links with Ireland and is set to get stronger
Mulligan backs ONK Therapeutics in $8m funding
Galway company is developing enhanced natural killer cells to target cancers
European shares end lower on poor inflation data but gain for August
Travel and leisure stocks outperform in August, adding nearly 15%
Iseq outpaces other European indices as virus fears stalk markets
Markets report: Stronger sterling drags down UK blue chips on FTSE 100
Covid-19 vaccine hopes pull markets into positive territory
Iseq all-share index closes 0.3% up, with best performers coming from the transport sector
Kildare software company plots expansion with 100 new jobs
Odyssey VC specialises in services for companies operating in highly regulated sectors
Novartis takes on Sanofi, Amgen with $9.7bn takeover of heart drug maker
Swiss drugmaker betting on cholesterol-lowering prospect
Mixed bag for global equity markets as traders await economic stimulus
German Dax rises to six-week high as Iseq falls by almost a third of 1% on thin trading volumes
Sale of psoriasis drug Otezla will clear way for €74m Celgene deal
Bristol-Myers Squibb’s acquisition of Celgene goes ahead after Amgen pays €13.4bn for drug
Stocks decline over trade and growth concerns
In Dublin, the Iseq index closed down 0.3 per cent, with financial stocks declining again
Healthcare sector drags European share indices back into the black
London’s Ftse 100 also bagged gains as investors flocked to defensive stocks
Amgen drug takes aim at cancer ‘master switch’
World’s largest biotech company has discovered a drug to target a supposedly ‘undruggable’ gene mutation
College fees, paid work experience, career mentoring: the new face of GAA sponsorship
GAA top brass sees Cuala-Amgen deal as offering a template for other sponsors
US biotech accuses Irish pharma of infringing patent protection
Genentech says Dublin-based Amgen’s cancer treatment drug is infringing its patent
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices